BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22926302)

  • 21. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenal neoplasms: CT-guided radiofrequency ablation--preliminary results.
    Mayo-Smith WW; Dupuy DE
    Radiology; 2004 Apr; 231(1):225-30. PubMed ID: 14990812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of General Anesthesia and Conscious Sedation During Computed Tomography-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma.
    Kim HJ; Park BK; Chung IS
    Can Assoc Radiol J; 2018 Feb; 69(1):24-29. PubMed ID: 29198818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
    Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
    Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency ablation of synchronous bilateral renal cell carcinoma.
    Zhang S; Zhao X; Ji C; Liu G; Li X; Zhang G; Gan W; Guo H
    Int J Urol; 2012 Mar; 19(3):241-7. PubMed ID: 22129157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Assessment of Chronic Kidney Disease following Microwave Ablation for Stage T1 Renal Cell Carcinoma.
    Zhou W; Herwald SE; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2018 Dec; 29(12):1685-1691. PubMed ID: 30297311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT-Guided Microwave Ablation of 45 Renal Tumors: Analysis of Procedure Complexity Utilizing a Percutaneous Renal Ablation Complexity Scoring System.
    Mansilla AV; Bivins EE; Contreras F; Hernandez MA; Kohler N; Pepe JW
    J Vasc Interv Radiol; 2017 Feb; 28(2):222-229. PubMed ID: 27988263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chyluria after radiofrequency ablation of renal tumors.
    Kaur H; Matin SF; Javadi S; Johnson VE; Choi H; Sandler C; Ahrar K
    J Vasc Interv Radiol; 2011 Jul; 22(7):924-7. PubMed ID: 21507680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous microwave ablation of renal cancers under CT guidance: safety and efficacy with a 2-year follow-up.
    Chan P; Vélasco S; Vesselle G; Boucebci S; Herpe G; Debaene B; Ingrand P; Irani J; Tasu JP
    Clin Radiol; 2017 Sep; 72(9):786-792. PubMed ID: 28545682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
    Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients.
    Zhao X; Wang W; Zhang S; Liu J; Zhang F; Ji C; Li X; Gan W; Zhang G; Guo H
    Abdom Imaging; 2012 Oct; 37(5):885-91. PubMed ID: 22131041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients.
    Iannuccilli JD; Dupuy DE; Beland MD; Machan JT; Golijanin DJ; Mayo-Smith WW
    Eur Radiol; 2016 Jun; 26(6):1656-64. PubMed ID: 26373755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of ultrasound-guided radiofrequency ablation in the treatment of 36 renal cell carcinoma tumours compared with published results of using computed tomography guidance.
    Davis K; Kielar A; Jafari K
    Can Assoc Radiol J; 2012 Aug; 63(3 Suppl):S23-32. PubMed ID: 21145195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic radiofrequency for small renal masses. What is the best imaging technique?
    Gallego Vilar D; Cifrian García M; García Fadrique G; García Vila J; Gallego Gómez J
    Arch Esp Urol; 2013; 66(1):60-70. PubMed ID: 23406801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.
    Clark TW; Malkowicz B; Stavropoulos SW; Sanchez R; Soulen MC; Itkin M; Patel A; Mondschein JI; Wein AJ
    J Vasc Interv Radiol; 2006 Mar; 17(3):513-9. PubMed ID: 16567676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multipolar hepatic radiofrequency ablation using up to six applicators: preliminary results.
    Bruners P; Schmitz-Rode T; Günther RW; Mahnken A
    Rofo; 2008 Mar; 180(3):216-22. PubMed ID: 18278730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
    Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
    J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
    Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
    Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.